A. Rojas

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults

A. Sette, D. Weiskopf, C. Asenjo, 2022, eBioMedicine.

Immunogenicity and safety of booster CYD-TDV dengue vaccine after alternative primary vaccination schedules in healthy individuals aged 9-50 years: a randomised, controlled, phase 2, non-inferiority study.

M. R. Capeding, G. Dayan, B. Zambrano, 2022, The Lancet. Infectious diseases.

Differential immune response induced by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial

D. Weiskopf, A. Grifoni, R. Soto-Rifo, 2022, medRxiv.

Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9-50 years (CYD65): a randomised, controlled, phase 2, non-inferiority study.

C. Diazgranados, M. R. Capeding, G. Dayan, 2020, The Lancet. Infectious diseases.

Real-time RT-PCR for Venezuelan equine encephalitis complex, Madariaga and Eastern equine encephalitis viruses: application in clinical diagnostic and mosquito surveillance

Nuno R. Faria, C. Donnelly, J. Pascale, 2022, medRxiv.